| Gene: | PTK2 |
| GeneID: | ENSG00000169398 |
| Chrom: | 8 |
| Start position: | 140657900 |
| End position: | 141002216 |
| Pathway: | Chemokine signaling pathway |
| Class: | Organismal Systems; Immune system |
| FST gene level: | 0.0770111 |
| Number of nsSNPs: | 1 |
| nsSNPs in gene: | rs79812711 |
| Gene Structure: |  |
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
| Gscore (Amp): | 0.91 (Driver) | | Gscore (Del): | 0.00 |
|
|
| Recurrently amplified in 3 cancer type(s) | |
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| Functional class: | Kinase (protein kinase) |
| JensenLab PubMed score: | 1038.29 (Percentile rank: 95.53%) |
| PubTator score: | 1563.61 (Percentile rank: 97.75%) |
| Target development/druggability level: | TchemThese targets have activities in ChEMBL or DrugCentral that satisfy the activity thresholds detailed below. |
| Tractability (small molecule): | Clinical PrecedenceTargets with drugs in phase II or above; Pre-clinical targets |
| Tractability (antibody): | Predicted Tractable - High confidenceTargets located in the plasma membrane; Targets with GO cell component terms plasma membrane or secreted |
